250 related articles for article (PubMed ID: 8972227)
1. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.
Kubbutat MH; Vousden KH
Mol Cell Biol; 1997 Jan; 17(1):460-8. PubMed ID: 8972227
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
Mantovani F; Banks L
Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
Jones DL; Münger K
J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition.
Zhang W; Lu Q; Xie ZJ; Mellgren RL
Oncogene; 1997 Jan; 14(3):255-63. PubMed ID: 9018111
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition.
Brown J; Higo H; McKalip A; Herman B
J Cell Biochem; 1997 Aug; 66(2):245-55. PubMed ID: 9213225
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
An WG; Chuman Y; Fojo T; Blagosklonny MV
Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
[TBL] [Abstract][Full Text] [Related]
8. On the involvement of calpains in the degradation of the tumor suppressor protein p53.
Gonen H; Shkedy D; Barnoy S; Kosower NS; Ciechanover A
FEBS Lett; 1997 Apr; 406(1-2):17-22. PubMed ID: 9109377
[TBL] [Abstract][Full Text] [Related]
9. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
10. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6.
Crook T; Ludwig RL; Marston NJ; Willkomm D; Vousden KH
Virology; 1996 Mar; 217(1):285-92. PubMed ID: 8599213
[TBL] [Abstract][Full Text] [Related]
12. The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein.
Srivenugopal KS; Ali-Osman F
Oncogene; 2002 Aug; 21(38):5940-5. PubMed ID: 12185595
[TBL] [Abstract][Full Text] [Related]
13. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.
Foster SA; Demers GW; Etscheid BG; Galloway DA
J Virol; 1994 Sep; 68(9):5698-705. PubMed ID: 8057451
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
[TBL] [Abstract][Full Text] [Related]
15. Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein.
Eichten A; Westfall M; Pietenpol JA; Münger K
Virology; 2002 Mar; 295(1):74-85. PubMed ID: 12033767
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
17. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin-induced apoptosis is regulated by endoplasmic reticulum stress- and calpain-mediated mitochondrial cell death pathways.
Lee MJ; Kee KH; Suh CH; Lim SC; Oh SH
Toxicology; 2009 Oct; 264(3):205-14. PubMed ID: 19699254
[TBL] [Abstract][Full Text] [Related]
19. Evidence for involvement of calpain in c-Myc proteolysis in vivo.
Small GW; Chou TY; Dang CV; Orlowski RZ
Arch Biochem Biophys; 2002 Apr; 400(2):151-61. PubMed ID: 12054425
[TBL] [Abstract][Full Text] [Related]
20. p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.
Molinari M; Milner J
Oncogene; 1995 May; 10(9):1849-54. PubMed ID: 7753560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]